featured
Anthracycline-Related Cardiotoxicity in Patients With Breast Cancer Harboring Homologous Recombination Deficiency Mutational Signature
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)
ESMO Open 2023 Dec 19;9(1)102196, L Incorvaia, G Badalamenti, G Novo, S Gori, L Cortesi, C Brando, S Cinieri, G Curigliano, GR Ricciardi, A Toss, R Chiari, R Berardi, Z Ballatore, M Bono, TD Bazan Russo, V Gristina, A Galvano, G Damerino, L Blasi, V Bazan, A RussoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.